SCHEMBL6325947

SCHEMBL6325947

CCC(Cl)(NCc1ccccc1)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.50
ALDH1A1 P00352 2/20 0.44
MAPT P10636 1/20 0.44
PPID Q08752 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 1/20 0.41
RAB9A P51151 1/20 0.41
EPHX2 P34913 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CA12 O43570 2/20 0.40
CA7 P43166 2/20 0.40
CA14 Q9ULX7 2/20 0.40
CA2 P00918 2/20 0.40
CA1 P00915 2/20 0.40
GAA P10253 1/20 0.40
THRB P10828 1/20 0.39
IDO1 P14902 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2953732 0.85 RIPK1 (0.46) RIPK1ALDH1A1MAPTPPIDSMN1; SMN2
SCHEMBL28514172 0.83 POLB (0.47) ALDH1A1MAPTSMN1; SMN2RAB9ACYP3A4
SCHEMBL28825841 0.78 THRB (0.45) RIPK1ALDH1A1SMN1; SMN2LMNARAB9A
SCHEMBL2540383 0.77 RIPK1 (0.56) RIPK1ALDH1A1MAPTPPIDSMN1; SMN2
SCHEMBL1508831 0.77 RIPK1 (0.56) RIPK1ALDH1A1MAPTPPIDSMN1; SMN2
SCHEMBL20424191 0.77 RIPK1 (0.51) RIPK1ALDH1A1MAPTPPIDSMN1; SMN2
SCHEMBL1508717 0.77 RIPK1 (0.56) RIPK1ALDH1A1MAPTPPIDSMN1; SMN2
SCHEMBL11526495 0.77 RIPK1 (0.46) RIPK1ALDH1A1MAPTLMNARAB9A
SCHEMBL28571249 0.75 MAPT (0.40) ALDH1A1MAPTSMN1; SMN2LMNAEPHX2
SCHEMBL24965924 0.74 RIPK1 (0.51) RIPK1ALDH1A1MAPTPPIDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260071008-A1 HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME KUREHA CORPORATION (JP) 2026-03-12 US disclosed
EP-4582460-A1 HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME Kureha Corporation (JP) 2025-07-09 EP disclosed
CN-119768440-A Hydrophobically modified cellulose fibers and process for producing the same 株式会社吴羽 2025-04-04 CN disclosed
CN-118108372-A Coalescing technology for removing CPMABA in PPS brine 浙江新和成特种材料有限公司 2024-05-31 CN disclosed
WO-2024048610-A1 HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME 株式会社クレハ 2024-03-07 WO disclosed
CN-108026275-B Method for producing polyarylene sulfide 株式会社吴羽 2020-05-15 CN disclosed
US-20050228095-A1 Polyarylene sulfide resin composition and molded article therefrom Polyplastic Co., Ltd., (JP) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260071008-A1 HYDROPHOBICALLY MODIFIED CELLULOSE FIBERS AND METHOD FOR PRODUCING SAME GANAB, ALG1, GANC RIPK1 2932/4885ALDH1A1 2401/4885MAPT 847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.